Nuclear dots: Actors on many stages

Immunobiology

Volumn 198, Issue 1-3, 1997, Pages 307-331

  Sternsdorf, Thomas ^a   Grötzinger, Thilo ^a   Jensen, Kirsten ^a   Will, Hans ^a,b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; INTERFERON; VIRUS PROTEIN;

ACUTE MYELOBLASTIC LEUKEMIA; ADENOVIRUS; CELL CYCLE; CELL NUCLEUS INCLUSION BODY; CYTOLOGY; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOLOGY; INFLUENZA VIRUS; NONHUMAN; ONCOGENE; ONCOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REVIEW; TRANSACTIVATION; VIROLOGY;

EID: 2642601103     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0171-2985(97)80051-4     Document Type: Article

References (128)

1. RASKA, I. M. DUNDR, and K. KOBERNA. 1992. Structure-function subcompartments of the mammalian cell nucleus as revealed by the electron microscopic affinity cytochemistry. Cell Biol. Int. Rep. 16: 771-789.
2. STROUBOULIS, J. and A. P. WOLFFE. 1996. Functional compartmentalization of the nucleus. J. Cell. Sci. 109: 1991.
3. HADLACZKY, G., M. WENT and N. R. RINGERTZ. 1986. Direct evidence for the non-random localization of mammalian chromosomes in the interphase nucleus. Exp. Cell. Res. 167: 1.
4. LICHTER, P., T. CREMER, J. BORDEN, L. MANUELIDIS and D. C. WARD. 1988. Delineation of individual human chromosomes in metaphase and interphase cells by in situ suppression hybridization using recombinant DNA libraries. Hum. Genet. 80: 224.
5. DE GRAAF, A., B. M. HUMBEL, N. STUURMAN, P. M. VAN BERGEN EN HENEGOUWEN, and A. J. VERKLEIJ. 1992. Three-dimensional immunogold labeling of nuclear matrix proteins in permeabilized cells. Cell Biol. Int. Rep. 16: 827.
6. CAPCO, D. G., K. D. WAN and S. PENMAN. 1982. The nuclear matrix: Three-dimensional architecture and protein composition. Cell 29: 847.
7. SCHEER, U. and R. BENAVENTE. 1990. Functional and dynamic aspects of the mammalian nucleolus. BioEssays 12: 14.
8. NAKAMURA, H., T. MORITA, and C. SATO. 1986. Structural organization of replicon domains during DNA synthetic phase in the mammalian nucleus. Exp. Cell. Res. 165: 291.
9. ZIRBEL, R. M., U. R. MATHIEU, A. KURZ, T. CREMER, and P. LICHTER. 1993. Evidence for a nuclear compartment of transcription and splicing located at chromosome domain boundaries. Chromosome Res. 1: 93.
10. FAKAN, S. 1994. Perichromatin fibrils are in situ forms of nascent transcripts. Trends Cell Biol. 4: 86.
11. XING, Y., C. V. JOHNSON, P. R. DOBNER, and J. B. LAWRENCE. 1993. Higher level organization of individual gene transcription and RNA splicing. Science 259: 1326.
12. BRASCH, K. and R. L. OCHS. 1992. Nuclear bodies (NBs): A newly «rediscovered» organelle. Exp. Cell. Res. 202: 211.
13. ANDRADE, L. E., E. K. CHAN, I. RASKA, C. L. PEEBLES, G. ROOS, and E. M. TAN. 1991. Human autoantibody to a novel protein of the nuclear coiled body: immunological characterization and cDNA cloning of p80-coilin. J. Exp. Med. 173: 1407.
14. SILLEKENS, P. T., W. J. HABTES, R. P. BEIJER, and W. J. VAN VENROIJ. 1987. cDNA cloning of the human U1 snRNA-associated A protein: extensive homology between U1 and U2 snRNP-specific proteins. EMBO J. 6: 3841.
15. TAN, E. M. 1989. Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology. Adv. Immunol. 44: 93.
16. TAN, E. M. 1991. Autoantibodies in pathology and cell biology. Cell 67: 841.
17. COURVALIN, J. C., K. LASSOUED, E. BARTNIK, G. BLOBEL, and R. W. WOZNIAK. 1990. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J. Clin. Invest. 86: 279.
18. BERNSTEIN, R. M., J. M. NEUBERGER, C. C. BUNN, M. E. CALLENDER, G. R. HUGHES, and R. WILLIAMS. 1984. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin. Exp. Immunol. 55: 553.
19. POWELL, F., A. L. SCHROETER, and E. R. DICKSON. 1984. Anti-nuclear antibodies in primary biliary cirrhosis. Lancet 1: 288.
20. CASSANI, F., F. B. BIANCHI, M. LENZI, U. VOLTA, and E. PISI. 1985. Immunomorphological characterisation of anti-nuclear antibodies in chronic liver disease. J. Clin. Pathol. 38: 801.
21. DYCK, J. A., G. G. MAUL, W. J. MILLER, J. D. CHEN, A. KAKIZUKA, and R. M. EVANS. 1994. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76: 333.
22. WEIS, K., S. RAMBAUD, C. LAVAU, J. JANSEN, T. CARVALHO, M. CARMO-FONSECA, A. LAMOND, and A. DEJEAN. 1994. Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell 76: 345.
23. ASCOLI, C. A. and G. G. MAUL. 1991. Identification of a novel nuclear domain. J. Cell. Biol. 112: 785.
24. LAMOND, A. I. and M. CARMO-FONSECA. 1993. The coiled body. Trends Cell Biol. 3: 198.
25. ZUBER, M., T. S. HEYDEN, and A. M. LAJOUSPETTER. 1995. A human autoantibody recognizing nuclear matrix-associated nuclear protein localized in dot structures. Biol. Cell. 85: 77.
26. KAMEI, H. 1995. A nulear dot-like structures that has a relationship with perinuclear intermediate filaments. Exp. Cell. Res. 218: 155.
27. SZOSTECKI, C., H. KRIPPNER, E. PENNER, and F. A. BAUTZ. 1987. Autoimmune sera recognize a 100 kD nuclear protein antigen (Sp100). Clin. Exp. Immunol. 68: 108.
28. SZOSTECKI, C., H. H. GULDNER, H. J. NETTER, and H. WILL. 1990. Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodoes from patients with primary biliary cirrhosis. J. Immuno. 145: 4338.
29. SZOSTECKI, C., H. WILL, H. J. NETTER, and H. H. GULDNER. 1990. Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution. Scand. J. Immunol. 36: 555.
30. XIE, K. and M. SNYDER. 1995. Two short autoepitopes on the nuclear dot antigen are similar to epitopes encoded by the Epstein-Barr virus Proc. Natl. Acad. Sci. USA. 92: 1639.
31. ZÜCHNER, D., T. STERNSDORF, C. SZOSTECKI, E. J. HEATHCOTE, K. CAUCH-DUDEK, and H. WILL. in press. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and PML in a large cohort of patients with primary biliary cirrhosis. Hepatology.
32. STERNSDORF, T., H. H. GULDNER, C. SZOSTECKI, T. GRÖTZINGER, and H. WILL. 1995. Two nuclear-dot associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand. J. Immunol. 42: 257.
33. FATENEJAD, S., W. BROOKS, A. SCHWARTZ, and J. CRAFT. 1994. Pattern of anti-small nuclear ribonucleoprotein antibodies in MRL/Mp-lpr/lpr mice suggests that the intact U1 snRNP particle is their autoimmunogenic target. J. Immunol. 152: 5523.
34. SZOSTECKI, C. 1991. Studien zur Struktur, Expression und Funktion des nukleären Sp100-Autoantigenes und Analyse der humoralen Immunantwort. Ludwig-Maximilians-Universität München. PhD thesis.
35. XIE, K., J. LAMBIE, and M. SNYDER. 1993. Nuclear dot antigens may specify transcriptional domains in the nucleus. Mol. Cell. Biol. 13: 6170.
36. DENT, A. L., J. YEWDELL, F. PUVIONDUTILLEUL, M. H. M. KOKEN, H. DE THÉ, and L. M. STAUDT. 1996. LYSP100-associated nuclear domains (LANDs): Description of a new class of subnuclear structures and their relationship to PML nuclear bodies Blood 88: 1423.
37. Guldner, H. H., C. SZOSTECKI, and H. WILL. Submitted. Interferon-inducible splice variants of the nuclear dot-associated transcriptional regulatory protein Sp100 containing domains with homologies to cytokine responsive nuclear phosphoproteins and HMG-1.
38. GRÖTZINGER, T., K. JENSEN, H. H. GULDNER, T. STERNSDORF, C. SZOSTECKI, M. SCHWAB, L. SAVELYEVA, B. REICH, and H. WILL. 1996. A highly amplified mouse gene is homologous to the human interferon-responsive Sp100 gene encoding an autoantigen associated with nuclear dots. Mol. Cell. Biol. 16: 1150.
39. PLASS, C., D. WEICHENHAN, B. KUNZE, T. HELLWIG, C. SCHNEIDER, F. A. BAUTZ, K. H. GRZESCHIK, W. TRAUT, and H. WINKING. 1995. A member of the mouse LRR transcript family with homology to the human Sp100 gene. Hereditas. 122: 245.
40. AGULNIK, S., C. PLASS, W. TRAUT, and H. WINKING. 1993. Evolution of a long-range repeat family in chromosome 1 of the genus Mus. Mamm. Genome. 4: 704.
41. PURMANN, L., C. PLASS, M. GRUNEBERG, H. WINKING, and W. TRAUT. 1992. A long-range repeat cluster in chromosome 1 of the house mouse, Mus musculus, and its relation to a germline homogeneously staining region. Genomics 12: 80.
42. FAKHARZADEH, S. S., S. P. TRUSKO, and D. L. GEORGE. 1991. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10: 1565.
43. ANAGNOU, N. P., S. J. O'BRIEN, T. SHIMADA, W. G. NASH, M. J. CHEN, and A. W. NIENHUIS. 1984: Chromosomal organization of the human dihydrofolate reductase genes: dispersion, selective amplification, and a novel form of polymorphism. Proc. Natl. Acad. Sci. USA. 81: 5170.
44. ECKERT, W. A., C. PLASS, A. WEITH, W. TRAUT, and H. WINKING. 1991. Transcripts from amplified sequences of an inherited homogeneously staining region in chromosome 1 of the house mouse (Mus musculus). Mol. Cell. Biol. 11: 2229.
45. WEICHENHAN, D., B. KUNZE, C. PLASS, T. HELLWIG, H. WINKING, and W. TRAUT. 1995. A transcript family from a long-range repeat cluster of the house mouse. Genomics 38: 239.
46. BLOCH, D. B., S. M. DE LA MONTE, P. GUIGAOURI, A. FILIPPOV, and K. D. BLOCH. 1996. Identification and characterization of a leukocyte-specific component of the nuclear body. J. Biol. Chem. 271: 29198.
47. KOKEN, M. H. M., D. F. PUVION, M. C. GUILLEMIN, A. VIRON, G. LINARES-CRUZ, N. STUURMAN, L. DE JONG, C. SZOSTECKI, F. CALVO, C. CHOMIENNE, L. DEGOS, E. PUVION, and H. DE THÉ. 1994. The t(15; 17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13: 1073.
48. KADEREIT, S., D. R. GEWERT, J. GALABRU, A. G. HOVANESSIAN, and E. F. MEURS. 1993. Molecular cloning of two new interferon-induced, highly related nuclear phosphoproteins. J. Biol. Chem. 268: 24432.
49. GROSSCHEDL, R. K., K. GIESE, and J. PAGEL. 1994. HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. Trends Genet. 10: 94.
50. ONATE, S. A., P. PRENDERGAST, J. P. WAGNER, M. NISSEN, R. REEVES, D. E. PETTIJOHN, and D. P. EDWARDS. 1994. The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences. Mol. Cell. Biol. 14: 3376.
51. LEHMING, N., D. THANOS, J. M. BRICKMAN, J. MA, T. MANIATIS, and M. PTASHNE. 1994. An HMG-like protein that can switch a transcriptional activator to a repressor. Nature 371: 175.
52. LAUDET, V., D. STEHELIN, and H. CLEVERS. 1993. Ancestry and diversity of the HMG box superfamily. Nucleic Acids Res. 21: 2493.
53. DE THÉ, H., C. CHOMIENNE, M. LANOTTE, L. DEGOS, and A. DEJEAN. 1990. The t(15; 17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus. Nature 347: 558.
54. GODDARD, A. D., J. BORROW, P. S. FREEMONT, and E. SOLOMON. 1991. Characterization of a zinc finger gene disrupted by the t(15; 17) in acute promyelocytic leukemia. Science 254: 1371.
55. GRISOLANO, J. L., R. L. WESSELSCHMIDT, P. G. PELICCI, and T. J. LEY. 1997. Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAK alpha under control of cathepsin G regulaory sequences. Blood 89: 376.
56. ALTABEF, M., M. GARCIA, C. LAVAU, S.-C. BAE, A. DEJEAN, and J. SAMARUT. 1996. A retrovirus carrying the promyelocyte-retinoic acid receptor PML-RARα fusion gene transforms haematopoietic progenitors in vitro and induces acute leukaemias. EMBO J. 15: 2707.
57. HUANG, M. E., Y. C. YE, S. R. CHEN, J. R. CHAI, J. X. LU, L. ZHOA, L. J. GU, and Z. Y. WANG. 1988. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 72: 567.
58. DEGOS, L. 1994. Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survival [editorial]. Leukemia 8: 911.
59. DANIEL, M. T., M. H. M. KOKEN, O. ROMAGNE, S. BARBEY, A. BAZARBACHI, M. STADLER, M. C. GUILLEMIN, L. DEGOS, C. CHOMIENNE, and H. DE THÉ. 1993. PML protein expression in hematopoietic and acute promyelocytic leukemia cells. Blood 82: 1858.
60. DUPREZ, E., J. R. LILLEHAUG, T. NAOE, and M. LANOTTE. 1996. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15; 17) promyelocytic leukemia NB4 cells expressing PML-RARα. Oncogene. 12: 2451.
61. ONODERA, M., T. KUNISADA, S. NISHIKAWA, Y. SAKIYAMA, S. MATSUMOTO, and S.-I. NISHIKAWA. 1995. Overexpression of retinoic acid receptor a suppresses myeloid cell differentiation at the promyelocyte stage. Oncogene. 11: 1291.
62. AHN, M.-J., K. NASON-BURCHENAL, M. M. MOASSER and E. DMITROVSKY. 1995. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RARα or PML. Oncogene. 10: 2307.
63. LE, X. F., P. YANG, and K. S. CHANG. 1996. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J. Biol. Chem. 271: 130.
64. KOKEN, M. H. M., G. LINARES-CRUZ, F. QUIGNON, A. VIRON, M. K. CHELBI-ALIX, J. SOBCZAK-THEPOT, L. JUHLIN, L. DEGOS, F. CALVO, and H. DE THÉ. 1995. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene. 10: 1315.
65. MU, Z. M., K. V. CHIN, J. H. LIU, G. LOZANO, and K. S. CHANG. 1994. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell.. Biol. 14: 6858.
66. LIU, J. H., Z. M. MU, and K. S. CHANG. 1995. PML suppresses oncogenic transformation of NLH/3T3 cells by activated neu. J. Exp. Med. 181: 1965.
67. GUIOCHON-MANTEL, A., J. F. SAVOURET, F. QUIGNON, K. DELABRE, E. MILGROM, and H. DE THÉ. 1995. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors. Mol. Endocrinol. 9: 1791.
68. GRANDE, M. A., I. VAN DER KRAAN, B. VAN STEENSEL, W. SCHUL, H. DE THÉ, H. T. VAN DER VOORT, L. DE JONG, and R. VAN DRIEL. 1996. PML-containing nuclear bodies: their spatial distribution in relation to other nuclear components. J. Cell. Biochem. 63: 280.
69. KASTNER, P., A. PEREZ, Y. LUTZ, E. C. ROCHETTE, M. P. GAUB, B. DURAND, M. LANOTTE, R. BERGER, and P. CHAMBON. 1992. Structure, localization and transcriptional properties of two clases of retinoic acid receptor alpha fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J. 11: 629.
70. PEREZ, A., P. KASTNER, S. SETHI, Y. LUTZ, C. REIBEL, and P. CHAMBON. 1993. PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR. EMBO J. 12: 3171.
71. BARLOW, P. N., B. LUISI, A. MILNER, M. ELLIOTT, and R. EVERETT. 1994. Structure of the C3HC4 domam by 1H-nuclear magnetic resonance spectroscopy. A new structural class of zinc-finger. J. Mol. Biol. 237: 201.
72. BORDEN, K., J. M. LALLY, S. R. MARTIN, N. J. OREILLY, E. SOLOMON, and P. S. FREEMONT. 1996. In vivo and in vitro characterization of the B1 and B2 zinc-binding domains from the acute promyelocytic leukemia protooncoprotein PML. Proc. Natl. Acad. Sci. USA. 93: 1601.
73. LOVERING, R., I. M. HANSON, K. L. BORDEN, S. MARTIN, N. J. O'REILLY, G. I. EVAN, D. RAHMAN, D. J. PAPPIN, J. TROWSDALE, and P. S. FREEMONT. 1993. Identification and preliminary characterization of a protein motif related to the zinc finger. Proc. Natl. Acad. Sci. USA. 90: 2112.
74. FREEMONT, P. S., I. M. HANSON, and J. TROWSDALE. 1991. A novel cysteine-rich sequence motiv. Cell 64: 483.
75. SAURIN, A. J., K. L. B. BORDEN, M. N. BODDY, and P. S. FREEMONT. 1996. Does this have a familiar RING? Trends Biochem. Sci. 21: 208.
76. LE DOUARIN, B., C. ZECHEL, J.-M. GARNIER, Y. LUTZ, L. TORA, B. PIERRAT, D. HEERY, H. GRONEMEYER, P. CHAMBON, and R. LOSSON. 1995. The N-termmal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J. 14: 2020.
77. HASEGAWA, N., T. IWASHITA, N. ASAI, H. MURAKAMI, Y. IWATA, T. ISOMURA, H. GOTO, T. HAYAKAWA, and M. TAKAHASHI. 1996. A RING finger motif regulates transforming activity of the rfp/ret fusion gene. Biochem. Biophys. Res. Commun. 225: 627.
78. DE THÉ, H., C. LAVAU, A. MARCHIO, C. CHOMIENNE, L. DEGOS, and A. DEJEAN. 1991. The PML-RAR alpha fusion mRNA generated by the t(15; 17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66: 675.
79. KAKIZUKA, A., W. J. MILLER, K. UMESONO, R. J. WARRELL, S. R. FRANKEL, V. V. MURTY, E. DMITROVSKY, and R. M. EVANS. 1991. Chromosomal translocation t(15; 17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 66: 663.
80. FAGIOLI, M., M. ALCALAY, P. P. PANDOLFI, L. VENTURINI, A. MENCARELLI, A. SIMEONE, D. ACAMPORA, F. GRIGNANI, and P. G. PELICCI. 1992. Alternative splicing of PML transcripts predicts coexpression of several carboxy-terminally different protein isoforms. Oncogene. 7: 1083.
81. CHELBI-ALIX, M. K., L. PELICANO, F. QUIGNON, M. H. M. KOKEN, L VENTURINI, M. STADLER, J. PAVLOVIC, L. DEGOS, and H. DE THÉ. 1995. Induction of the PML protein by interferons in normal and APL cells. Leukemia 9: 2027.
82. GRÖTZINGER, T., T. STERNSDORF, K. JENSEN, and H. WILL. 1996. Interferon-modulated expression of genes encoding the nuclear-dot-associated proteins Sp100 and promyelocytic leukemia protein (PML). Eur. J. Biochem. 238: 554.
83. DESBOIS, C., R. ROUSSET, F. BANTIGNIES, and P. JALINOT. 1996. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I tax oncoprotein. Science 273: 951.
84. MARCHETTI, A., F. BUTTITTA, S. MIYAZAKI, D. GALLAHAN, G. H. SMITH, and R. GALLAHAN. 1995. Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J. Virol. 69: 1932.
85. BODDY, M. N., K. HOWE, L. D. ETKIN, E. SOLOMON, and P. S. FREEMONT. 1996. PIC 1, a novel ubiquitin-like protein which interact with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene. 13: 971.
86. MAHAJAN, R., C. DELPHIN, T. GUAN, L. GERACE, and F. MELCHIOR. 1997. A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88: 97.
87. MATUNIS, M. J., E. COUTAVAS, and G. BLOBEL. 1996. A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell. Biol. 135: 1457.
88. OKURA, T., L. GONG, T. KAMITANI, T. WADA, I. OKURA, C. F. WEI, H. M. CHANG, and E. T. YEH. 1996. Protection against Fas/APO-1-and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J. Immunol. 157: 4277.
89. SHEN, Z., P. P. PARDINGTON, J. C. COMEAUX, R. K. MOYZIS, and D. J. CHEN. 1996. UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins. Genomics 36: 271.
90. LOEB, K. R. and A. L. HAAS. 1992. The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. J. Biol. Chem. 267: 7806.
91. WATKINS, J. F., P. SUNG, L. PRAKASH, and S. PRAKASH. 1993. The Saccharomyces cerevisiae DNA repair gene RAD23 encodes a nuclear protein containing a ubiquitin-like domain required for biological function. Mol. Cell. Biol. 13: 7757.
92. MELUH, P. B. and D. KOSHLAND. 1995. Suppressors of MIF2, a putative centomere protein gene in saccharomyces cerevisiae. Mol. Biol. Cell. 6(S): 2095.
93. BROWN, M. T., L. GOETSCH, and L. H. HARTWELL. 1993. MIF2 is required for mitotic spindle integrity during anaphase spindle elongation in Saccharomyces cerevisiae. J. Cell. Biol. 123: 387.
94. ARANY, Z., D. NEWSOME, E. OLDREAD, D. M. LIVINGSTON, and R. ECKNER. 1995. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374: 81.
95. KORIOTH, F., C. GIEFFERS, G. G. MAUL, and J. FREY. 1995. Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J. Cell. Biol. 130: 1.
96. BOEHM, T., L. FORONI, Y. KANEKO, M. F. PERUTZ, and T. H. RABBITTS. 1991. The rhombotin family of cystein-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13. Proc. Natl. Acad. Sci. USA. 88: 4367.
97. STERNSDORF, T., K. JENSEN, D. ZÜCHNER, and H. WILL. 1997. Cellular localization, expression, and structure of the nuclear dot protein 52. J. Cell Biol. 138: 435.
98. GRÖTZINGER, T., K. JENSEN, and H. WILL. 1996. The interferon (IFN)-stimulated gene Sp100 promoter contains an IFN-γ activation site and an imperfect IFN-stimulated response element which mediate type I IFN inducibility. J. Biol. Chem. 271: 25253.
99. STADLER, M., M. K. CHELBI-ALIX, M. H. KOKEN, L. VENTURINI, C. LEE, A. SAIB, F. QUIGNON, L. PELICANO, M. C. GUILLEMIN, C. SCHINDLER, and H. DE Thé. 1995. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene. 11: 2565.
100. WASYLYK, B., S. L. HAHN, and A. GIOVANE. 1993. The Ets family of transcription factors. Eur. J. Biochem. 211: 7.
101. GULDNER, H. H., C. SZOSTECKI, T. GRÖTZINGER, and H. WILL. 1992. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol. 149: 4067.
102. LAVAU, C., A. MARCHIO, M. FAGIOLI, J. JANSEN, B. FALINI, P. LEBON, F. GROVELD, P. P. PANDOLFI, P. G. PELICCI, and A. DEJEAN. 1995. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene. 11: 871.
103. DARNELL JR, J. E., I. M. KERR, and G. R. STARK. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415.
104. TERRIS, B., V. BALDIN, S. DUBOIS, C. DEGOTT, J. F. FLEJOU, D. HENIN, and A. DEJEAN. 1995. PML nuclear bodies are general targets to inflammation and cell proliferation. Cancer Res. 55: 1590.
105. GAMBACORTA, M., L. FLENGHI, M. FAGIOLI, S. PILERI, L. LEONCINI, B. BIGERNA, R. PACINI, L. N. TANCI, L. PASQUALUCCI, S. ASCANI, A. MENCARELLI, A. LISO, P. G. PELICCI, and B. FALINI. 1996. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues. Am. J. Pathol. 149: 2023.
106. MAUL, G. G., E. YU, A. M. ISHOV, and A. L. EPSTEIN. 1995. Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress. J. Cell. Biochem. 59: 498.
107. H. KAMEI. 1996. Reversible large-body formation form nuclear bodies upon amino acid(s) starvation in T24 cells. Exp. Cell. Res. 224: 302.
108. DOUCAS, V., A. M. ISHOV, A. ROMO, H. JUGUILON, M. D. WEITZMAN, R. M. EVANS, and G. G. MAUL. 1996. Adenovirus replication is coupled with the dynamic properties of the PML nucleae structure. Gene Develop. 10: 196.
109. MAUL, G. G., H. H. GULDNER, and J. G. SPIVACK. 1993. Modification of discrete nuclear domains induces by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J. Gen. Virol. 74: 2679.
110. MAUL, G. G. and R. D. EVERETT. 1994. HSV-1 IE Protein Vmw110 causes redistribution of PML. EMBO J. 13: 5062.
111. MULLEN, M. A., S. GERSTBERGER, D. M. CIUFO, J. D. MOSCA, and G. S. HAYWARD. 1995. Evaluation of colocalization interactions between the IE110, IE175, and IE63 transactivator proteins of herpes simplex virus within subcellular punctate structures. J. Virol. 69: 476.
112. EVERETT, R. D., C. M. PRESTON, and N. D. STOW. 1991. Functional and genetic analysis of the role of Vmw110 in herpes virus replication, CRC Press Publ., Boca Raton, FL.
113. PUVION-DUTILLEUL, F., L. VENTURINI, M. C. GUILLEMIN, H. DE THÉ, and E. PUVION. 1995. Sequestration of PML and Sp100 proteins in an intranuclear viral structure during herpes simplex virus type 1 infection. Exp. Cell. Res. 221: 448.
114. MAUL, G. G., A. M. ISHOV, and R. D. EVERETT. 1996. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology 217: 67.
115. KELLY, C., R. VAN DRIEL, and G. W. G. WILKINSON. 1995. Disruption of PML-associated nuclear bodies during human cytomegalovirus infection. J. Gen. Virol. 76: 2887.
116. KORIOTH, F., G. G. MAUL, B. PLACHTER, T. STAMMINGER, and J. FREY. 1996. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp. Cell. Res. 229:155.
117. SZEKELY, L., K. POKROVSKAJA, W. Q. JIANG, H. DE THÉ, N. RINGERTZ, and G. KLEIN. 1996. The Epstein-Barr virus-encoded nuclear antigen EBNA-5 accumulates in PML-containing bodies. J. Virol. 70: 2562.
118. PETTI, L., C. SAMPLE, and E. KIEFE. 1990. Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins. Virology 176: 563.
119. JIANG, W. Q., L. SZEKELY, H. V. WENDEL, N. RINGERTZ, G. KLEIN, and A. ROSEN. 1991. Co-localization of the retinoblastoma protein and the Epstein-Barr virus-encoded nuclear antigen EBNA-5. Exp. Cell. Res. 197: 314.
120. SZEKELY, L., G. SELIVANOVA, K. P. MAGNUSSON, G. KLEIN, and K. G. WIMAN. 1993. EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds of the retinoblastoma and p53 proteins. Proc. Natl. Acad. Sci. USA.90: 5455.
121. CARVALHO, T., J. S. SEELER, K. OHMAN, P. JORDAN, U. PETTERSSON, G. AKUSJARVI, M. CARMO-FONSECA, and A. DEJEAN. 1995. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell. Biol. 131: 45.
122. SZEKELY, L., W. Q. JIANG, K. POKROVSKAJA, K. G. WIMAN, G. KLEIN, and N. RINGERTZ 1995. Reversible nucleolar translocation of Epstein-Barr virus-encoded EBNA-5 and hsp70 proteins after exposure to heat shock or cell density congestion. J. Gen. Virol. 76: 2423.
123. NORDKVIST, K., K. ÖHMAN, and G. AKUSJÄRVI. 1994. Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs. Mol. Cell. Biol. 14: 437.
124. NERENBERG, M., S. H. HINRICHS, R. K. REYNOLDS, G. KHOURY, and G. JAY. 1987. The tat gene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice. Science 237: 1324.
125. GRASSMANN, R., S. BERCHTOLD, I. RADANT, M. ALT, B. FLECKENSTEIN, J. G. SODROSKI, W. A. HASELTINE, and U. RAMSTEDT. 1992. Role of human T-cell leukemia virus type 1 X region in immortalization of primary human lymphocytes in culture. J. Virol. 66: 4570.
126. STERNSDORF, T., K. JENSEN, and H. WILL. Submitted. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1.
127. WEICHENHAN, D., B. KUNZE, S. ZACKER, W. TRAUT, and H. WINKING. 1997. Structure and expression of the murine Sp100 nuclear dot gene. Genomics 43: 298-306.
128. GONGORA, C., G. DAVID, L. PINTARD, C. TISSOT, T. D. HUA, A. DEJEAN, and N. MECHTI. 1997. Molecular cloning of a new interferon-induced PML nuclear body-associated protein. J. Biol. Chem. 272: 19457-19463.